Punch & Associates Investment Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-17,000
Closed -$239K 211
2019
Q1
$239K Buy
17,000
+1,800
+12% +$30.9K 0.02% 197
2018
Q4
$241K Buy
15,200
+5,200
+52% +$89.6K 0.02% 203
2018
Q3
$188K Buy
+10,000
New +$199K 0.01% 207
2016
Q3
Sell
-95,360
Closed -$1.31M 182
2016
Q2
$1.31M Sell
95,360
-52,548
-36% -$730K 0.15% 161
2016
Q1
$2.03M Sell
147,908
-45,592
-24% -$523K 0.25% 139
2015
Q4
$1.96M Hold
193,500
0.24% 138
2015
Q3
$1.95M Hold
193,500
0.27% 141
2015
Q2
$2.87M Hold
193,500
0.36% 116
2015
Q1
$3.21M Hold
193,500
0.4% 101
2014
Q4
$2.93M Hold
193,500
0.38% 111
2014
Q3
$2.74M Hold
193,500
0.38% 119
2014
Q2
$2.74M Buy
193,500
+29,394
+18% +$446K 0.37% 118
2014
Q1
$2.81M Sell
164,106
-23,588
-13% -$391K 0.38% 113
2013
Q4
$2.76M Sell
187,694
-9,406
-5% -$129K 0.37% 116
2013
Q3
$2.61M Sell
197,100
-12,990
-6% -$161K 0.41% 109
2013
Q2
$2.26M Buy
+210,090
New +$2.36M 0.4% 121

Other funds holding PMD

Punch & Associates Investment Management's PMD Position: Q2 2019 in Review

Punch & Associates Investment Management sold out of Psychemedics Corporation (PMD) in Q2 2019, closing a stake of 17,000 shares — an estimated $239K sold.

Punch & Associates Investment Management first reported a position in PMD in Q2 2013 and held it in 16 quarters. The position peaked at $3.21M in Q1 2015. 46 funds tracked by Wall St. Rank hold PMD as of Q2 2019.

  • Punch & Associates Investment Management reported no remaining Psychemedics Corporation position as of Q2 2019 after selling out during the quarter.
  • Punch & Associates Investment Management sold 17,000 Psychemedics Corporation shares in Q2 2019, an estimated $239K.
  • Punch & Associates Investment Management first reported a position in Psychemedics Corporation in Q2 2013 and held it in 16 quarters.
  • Punch & Associates Investment Management's Psychemedics Corporation position peaked at $3.21M in Q1 2015.
  • 46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2019.

Based on Punch & Associates Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.